These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20973935)

  • 1. Mouse melanoma models and cell lines.
    Damsky WE; Bosenberg M
    Pigment Cell Melanoma Res; 2010 Dec; 23(6):853-9. PubMed ID: 20973935
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultraviolet radiation-induced malignant skin melanoma in melanoma-susceptible transgenic mice.
    Klein-Szanto AJ; Silvers WK; Mintz B
    Cancer Res; 1994 Sep; 54(17):4569-72. PubMed ID: 8062242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a nude mouse tumor model using beta-galactosidase-expressing melanoma cells.
    Dooley TP; Stamp-Cole M; Ouding RJ
    Lab Anim Sci; 1993 Feb; 43(1):48-57. PubMed ID: 7681492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocyte culture lines from Tyr-SV40E transgenic mice: models for the molecular genetic evolution of malignant melanoma.
    Larue L; Dougherty N; Bradl M; Mintz B
    Oncogene; 1993 Mar; 8(3):523-31. PubMed ID: 8382353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible reduction of hepatoma formation by Smmu 7721 cells in SCID mice and metastasis formation by B16F10 melanoma cells in C57BL/6 mice by Agaricus blazei murill extract.
    Wu MF; Lu HF; Hsu YM; Tang MC; Chen HC; Lee CS; Yang YY; Yeh MY; Chung HK; Huang YP; Wu CC; Chung JG
    In Vivo; 2011; 25(3):399-404. PubMed ID: 21576414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinically relevant, syngeneic model of spontaneous, highly metastatic B16 mouse melanoma.
    Bobek V; Kolostova K; Pinterova D; Kacprzak G; Adamiak J; Kolodziej J; Boubelik M; Kubecova M; Hoffman RM
    Anticancer Res; 2010 Dec; 30(12):4799-803. PubMed ID: 21187455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mouse model for skin malignant melanoma.
    Kato M; Takahashi M; Akhand AA; Liu W; Dai Y; Shimizu S; Iwamoto T; Suzuki H; Nakashima I
    Oncogene; 1998 Oct; 17(14):1885-8. PubMed ID: 9778055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment.
    Syed NA; Windle JJ; Darjatmoko SR; Lokken JM; Steeves RA; Chappell R; Wallow IH; Koop BA; Mangold G; Howes KA; Albert DM
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2800-5. PubMed ID: 9856795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.
    Watanabe D; Goshima F; Mori I; Tamada Y; Matsumoto Y; Nishiyama Y
    J Dermatol Sci; 2008 Jun; 50(3):185-96. PubMed ID: 18226503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.
    Miao Y; Owen NK; Fisher DR; Hoffman TJ; Quinn TP
    J Nucl Med; 2005 Jan; 46(1):121-9. PubMed ID: 15632042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
    Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
    Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of gene-therapy in combination with local X-irradiation in a mouse malignant melanoma model.
    Jin GH; Jin SZ; Liu Y; Xu RM; Yang JZ; Pan XN; Liu SZ
    Biochem Biophys Res Commun; 2005 May; 330(3):975-81. PubMed ID: 15809091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mice expressing the p75 CCAAT-displacement protein/Cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia.
    Cadieux C; Fournier S; Peterson AC; Bédard C; Bedell BJ; Nepveu A
    Cancer Res; 2006 Oct; 66(19):9492-501. PubMed ID: 17018605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of metastatic variants from heterogeneous tumor cell lines using the chicken chorioallantoic membrane and nude mouse.
    Dexter DL; Lee ES; DeFusco DJ; Libbey NP; Spremulli EN; Calabresi P
    Cancer Res; 1983 Apr; 43(4):1733-40. PubMed ID: 6831418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically engineered mouse melanoma and mouse Lewis lung carcinoma models.
    Galcheva-Gargova Z; Qi YW; Geisler S; Zhidkova N; Nugent MA; Venkataraman G
    Int J Oncol; 2005 May; 26(5):1233-9. PubMed ID: 15809714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
    Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
    J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenogeneic DNA immunization in melanoma models for minimal residual disease.
    Hawkins WG; Gold JS; Blachere NE; Bowne WB; Hoos A; Lewis JJ; Houghton AN
    J Surg Res; 2002 Feb; 102(2):137-43. PubMed ID: 11796010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia.
    Pollock PM; Cohen-Solal K; Sood R; Namkoong J; Martino JJ; Koganti A; Zhu H; Robbins C; Makalowska I; Shin SS; Marin Y; Roberts KG; Yudt LM; Chen A; Cheng J; Incao A; Pinkett HW; Graham CL; Dunn K; Crespo-Carbone SM; Mackason KR; Ryan KB; Sinsimer D; Goydos J; Reuhl KR; Eckhaus M; Meltzer PS; Pavan WJ; Trent JM; Chen S
    Nat Genet; 2003 May; 34(1):108-12. PubMed ID: 12704387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic cutaneous melanoma promoted by ultraviolet radiation in mice with transgene-initiated low melanoma susceptibility.
    Kelsall SR; Mintz B
    Cancer Res; 1998 Sep; 58(18):4061-5. PubMed ID: 9751610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated growth of melanomas after specific immune destruction of tumor stroma in a mouse model.
    Mintz B; Silvers WK
    Cancer Res; 1996 Feb; 56(3):463-6. PubMed ID: 8564953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.